Acceleron Pharma
Acceleron Pharma
Employees:
130
Market Cap:
$2.02 billion
Revenue:
$13.24 million
5 Year Trend:
2.4%
Net Income:
$-91.32 million
Stock:
XLRN

Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts. Wikipedia

Acceleron Pharma
Are you from Acceleron Pharma?

Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts. Wikipedia

Employees:
130
Market Cap:
$2.02 billion
Revenue:
$13.24 million
5 Year Trend:
2.4%
Net Income:
$-91.32 million
Stock:
XLRN

16 jobs at Acceleron Pharma

Jobs in